Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Liver Patients' hepatitis a protection under study

NCT ID NCT07433881

First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 12 times

Summary

This study checks how many adults with cirrhosis are immune to hepatitis A and how well a single vaccine dose works for those who aren't. About 360 participants will give blood samples and some will receive the vaccine. Results will help doctors decide who needs the shot.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Liver and Biliary Sciences

    New Delhi, National Capital Territory of Delhi, 110070, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.